NP Life Sciences Health Industry Group Inc.
ACAT· OTC
Filed Aug 16, 2021 · 10-Q · 47 days after period end · 0001493152-21-020099
| Metric | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|
| Revenue | — | $0.00 | $23.00K |
| Net Income | -$52.74K | -$53.65K | -$4.95K |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NP Life Sciences Health Industry Group Inc. · CIK 1781726 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 16, 2021 · 47 d after period end